Key Takeaways
- Sector: Agriculture Agribusiness & AgTech.
- Geography: Spain.
Analysis
Stirling Square Capital Partners-backed SAS Group has moved to reinforce its Iberian manufacturing base and broaden its product range with the acquisition of a majority stake in Codiagro, the Castellón‑based specialist in biostimulants and specialty plant nutrition. Financial terms were not disclosed.
The deal brings together SAS’s international distribution network and R&D platform with Codiagro’s formulation know‑how — notably its expertise in concentrated suspensions and Bag‑in‑Box packaging — and a catalogue of more than 65 SKUs targeting diverse crop needs. Management says the combination will accelerate product development and increase production flexibility at SAS’s expanded Lleida facilities.
Eduard Vallverdú, Chief Executive Officer of SAS Group, described the acquisition as a strategic fit that strengthens the company’s formulation toolkit and distribution footprint across Spain and abroad. Nieves Ruiz and Ricardo Pérez‑Santamarina, speaking for Codiagro, highlighted continuity for customers and an opportunity to scale R&D and exports while retaining the firm’s technical identity.
The transaction is the latest step in a roll‑up strategy executed since Stirling Square Capital Partners invested in SAS in 2021. SAS has pursued a mix of organic investment in R&D and targeted add‑ons – including earlier bolt‑ons in France, Portugal and Brazil – to expand both revenues and margins under a biosolutions platform approach.
The global biostimulants and speciality nutrition market is commonly estimated at around €3bn‑plus and is forecast to grow at roughly 10–12% CAGR over the coming decade as farmers seek yield and quality gains with lower chemical inputs. Consolidation has accelerated as manufacturers aim to combine formulation expertise, scale manufacturing and improve route‑to‑market across Europe and Latin America.
Enrico Biale, Partner at Stirling Square Capital Partners, said the firm will continue to support management with capital for R&D and capacity expansion as SAS targets further growth. Advisers on the deal included Deloitte and Cuatrecasas for the SAS side, with Codiagro advised by Auren and KPMG.